AI Integration for GE Neurology PACS

AI integration for GE Neurology PACS connects at three primary functional layers: the worklist manager, the advanced visualization viewer, and the reporting module. The integration is typically event-driven, triggered when a new CT or MRI brain study is archived to the PACS. Using DICOMweb or RESTful APIs from the GE Centricity or HealthCloud platform, the study is securely routed to an AI inference service. Core algorithms for hemorrhage detection (ICH), large vessel occlusion (LVO) identification, and quantitative brain volumetry run in parallel, with results returned as DICOM Structured Reports (SR) or JSON payloads containing coordinates, confidence scores, and measurements.

For the radiologist, AI findings are presented contextually within their existing workflow. In the viewer, subtle findings like a small basal ganglia hemorrhage can be highlighted with a bounding box overlay on the primary series. Quantitative results, such as hippocampal volume percentiles for dementia workups, are injected into a structured report template or displayed in a side panel. For acute stroke, a high-confidence LVO finding can automatically promote the study to the top of the emergency worklist and trigger an HL7 alert to the stroke team via existing notification systems, turning a potential 15-minute manual review into a <2-minute triage event.

Governance and rollout require a phased approach. Initial integration often starts with a silent mode, where AI runs in the background and results are logged but not displayed, building performance benchmarks and user trust. The next phase introduces findings as non-interruptive "second reader" annotations requiring radiologist verification before final sign-off. This human-in-the-loop design ensures the AI augments rather than replaces clinical judgment, maintains audit trails for compliance, and creates a feedback loop to retrain and improve model accuracy over time. Successful deployment hinges on aligning this technical integration with change management, ensuring the AI tools reduce cognitive load rather than adding new clicks to the neurologist or neuroradiologist's day.

The integration architecture typically uses GE's Centricity PACS APIs and DICOM Web Services to establish a secure, bidirectional data flow. Incoming brain CT and MRI studies from the modality or VNA are monitored. Key studies (e.g., non-contrast head CTs for stroke, brain MRIs for dementia) are automatically routed via a DICOM send to a dedicated, on-premises or cloud-based AI inference service. This service runs containerized models—for hemorrhage detection, large vessel occlusion (LVO) identification, or brain volumetry—and returns structured results as DICOM Structured Reports (SR) and annotated secondary capture images back to the PACS.

For the radiologist, this manifests as prioritized worklists and integrated findings. A critical LVO detection can trigger an HL7 ADT message to the stroke team pager system and bump the study to the top of the emergency worklist. Within the PACS viewer, AI findings appear as hanging protocol overlays—bounding boxes around a hemorrhage or color-coded ASPECTS regions—with the DICOM SR accessible in a side panel for quantitative details like hemorrhage volume or hippocampal atrophy percentages. This creates a seamless "AI-as-a-second-reader" workflow without forcing the radiologist to leave their primary diagnostic environment.

Governance and rollout are critical. A phased implementation starts with silent mode inference, where AI runs in the background without affecting workflows, allowing validation of model performance against historical reports. Rollout then progresses to concurrent notification within the PACS for a pilot user group, with clear audit trails logging every AI inference, user interaction, and override. This architecture, built with fault-tolerant queues and fallback pathways, ensures the core PACS reading workflow remains stable, while AI provides actionable support where it impacts clinical speed and accuracy most.

Integrating AI into a GE Neurology PACS requires a security-first architecture that respects clinical data integrity and workflow. The core pattern involves a secure, containerized AI inference service that receives DICOM studies via a DICOM C-STORE SCP or listens to a HL7 ADT/ORM feed from the RIS. AI results, formatted as DICOM Structured Reports (SR) or HL7 ORU messages, are injected back into the PACS worklist or the patient's imaging record. All data in transit and at rest must be encrypted, and access must be governed by the PACS's existing RBAC and audit trails to ensure only authorized users can view or act on AI findings.

A phased rollout is critical for clinical adoption and risk management. Phase 1 (Silent Mode) runs AI algorithms in the background, logging findings without displaying them to radiologists, to validate performance and establish baselines. Phase 2 (Assistive Mode) presents AI findings as non-interruptive overlays or a separate findings panel in the GE viewer, allowing radiologists to reference them during read. Phase 3 (Integrated Workflow) embeds AI triggers into the worklist, using confidence scores to prioritize studies (e.g., flagging potential large vessel occlusions for immediate review) and auto-populating structured report templates. Each phase requires clear change control, staff training, and defined processes for handling AI false positives/negatives.

Governance is anchored in the clinical team. Establish a multidisciplinary AI committee (neuroradiology, IT, compliance, biomedical engineering) to oversee model validation, algorithm updates, and incident review. Implement a feedback loop where radiologists can easily correct or dismiss AI findings; this data is essential for continuous model improvement and regulatory compliance. For tools like brain atrophy quantification, define acceptable variance thresholds and ensure the integration supports longitudinal tracking dashboards for dementia workups. The goal is a governed, secure system where AI acts as a consistent, auditable assistant, reducing time to treatment for stroke and cognitive decline patients without disrupting the diagnostic authority of the clinician.